Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.

Background: Steroid-sparing drugs, such as cyclosporine, are recommended as treatment for children with frequently relapsing nephrotic syndrome (FRNS) and steroid-related toxicities. We recently reported a high rate of relapsing nephrotic syndrome 2 years after discontinuation of cyclosporine treatm...

Descripción completa

Detalles Bibliográficos
Publicado en:Pediatric Nephrology Vol. 32; no. 8; pp. 1383 - 1391
Autores principales: Hamasaki, Yuko, Komaki, Fumiyo, Ishikura, Kenji, Hamada, Riku, Sakai, Tomoyuki, Hataya, Hiroshi, Ogata, Kentaro, Ando, Takashi, Honda, Masataka
Formato: research tables/charts Journal Article
Publicado: Springer Nature Aug2017
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=123732602&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 123732602
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        0931041X
        EF1
      jtl: Pediatric Nephrology
      issn: 0931041X
      maglogo: N
    pubinfo:
      dt: Aug2017
      vid: 32
      iid: 8
      pid: 237
      pub: Springer Nature
      place: New York, New York
    artinfo:
      ui:
        123732602
        123732602
        143999215
        123732602
        10.1007/s00467-017-3641-4
        123732602
      ppf: 1383
      ppct: 8
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Nephrotoxicity in children with frequently relapsing nephrotic syndrome receiving long-term cyclosporine treatment.
      aug:
        au:
          Hamasaki, Yuko
          Komaki, Fumiyo
          Ishikura, Kenji
          Hamada, Riku
          Sakai, Tomoyuki
          Hataya, Hiroshi
          Ogata, Kentaro
          Ando, Takashi
          Honda, Masataka
        affil: Division of Infectious Diseases Control , Health and Welfare Bureau Health Center of Kawasaki City , Kanagawa Japan
      sug:
        subj:
          Cyclosporine Administration and Dosage
          Nephrotic Syndrome Drug Therapy
          Nephrotoxicity Etiology
          Cyclosporine Adverse Effects
          Recurrence Drug Therapy
          Human
          Treatment Duration
          Retrospective Design
          Fibrosis
          Descriptive Statistics
          Male
          Female
          Child
          Arteries Pathology
          Odds Ratio
          Confidence Intervals
          Biopsy
          Drug Monitoring
          Child: 6-12 years
          Male
          Female
      ab: Background: Steroid-sparing drugs, such as cyclosporine, are recommended as treatment for children with frequently relapsing nephrotic syndrome (FRNS) and steroid-related toxicities. We recently reported a high rate of relapsing nephrotic syndrome 2 years after discontinuation of cyclosporine treatment, suggesting that long-term treatment is necessary. Cyclosporine-associated nephrotoxicity (CAN) is a potential side effect of long-term cyclosporine treatment. Methods: We retrospectively reviewed pediatric patients with FRNS treated with cyclosporine for ≥3 years at a single center between 1999 and 2012. The cyclosporine dose was adjusted to maintain the whole-blood cyclosporine trough level at 80-100 ng/ml for 6 months, at 60-80 ng/ml for 18 months, and then at around 50-60 ng/ml thereafter. Maintenance dose of prednisolone was not prescribed. CAN was graded in terms of arteriolar hyalinosis and the degree of interstitial fibrosis. Results: Thirty-six children (28 males) were enrolled in the study. The median age at the start of long-term cyclosporine treatment was 9.4 years. The median duration of the longest period of cyclosporine treatment was 4.5 years. Most CAN cases were characterized by arteriolar hyalinosis. The frequency of CAN was positively correlated with the duration of cyclosporine treatment, with an odds ratio (95% confidence interval) for CAN of 3.84 (0.79-18.74) after 2-5 years and 6.60 (1.18-36.94) after >5 years of cyclosporine treatment (vs. 0-2 years). Conclusions: Although the frequency of CAN was correlated with the duration of cyclosporine treatment in our pediatric patient population, most cases of CAN involved arteriolar hyalinosis. We conclude that long-term cyclosporine treatment is useful for treating FRNS in children, providing its dose is controlled and kidney biopsies are regularly performed.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N